Nykode Therapeutics ASA — Director's Dealing 2024

Mar 13, 2024

Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider

Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider

Oslo, Norway, March 13, 2024 - Primary insider Harald Gurvin, Chief Financial Officer of Nykode Therapeutics ASA, has today acquired 10,000 shares in Nykode Therapeutics ASA at an average price of NOK 14.00 per share. Following the transaction, Harald Gurvin holds 30,000 shares in Nykode Therapeutics ASA.

Please see further details in the attached document.